Gold, the traditional safe haven asset, has recently experienced a notable, albeit shallow, pullback from its record highs in late 2025. After soaring to unprecedented levels, the precious metal saw a correction, sparking discussions among investors and analysts about its immediate trajectory. This recent dip, characterized by a decline of
A quiet revolution is brewing in the staid world of finance, threatening to upend centuries-old practices of how company ownership is recorded, traded, and settled. The concept of "stocks on a blockchain," often referred to as tokenized stocks or security tokens, introduces a digital paradigm where traditional shares are converted
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official boosted investor optimism for a potential interest rate cut.
Shares of payment solutions provider WEX (NYSE:WEX) jumped 4.9% in the afternoon session after investors grew more optimistic about a potential Federal Reserve interest rate cut in December.
Broadridge Financial Solutions has notably lagged behind the broader market over the past year, and analysts remain cautious about the stock’s prospects.
The Home Depot (NYSE: HD), the world's largest home improvement retailer, recently announced a quarterly cash dividend of $2.30 per share, reaffirming its commitment to delivering consistent shareholder value. This declaration, made on August 21, 2025, for shareholders of record as of September 4, 2025, with payment due on
Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.
In a financial landscape increasingly defined by volatility and uncertainty, gold and silver have emerged as undeniable beacons of stability, their prices surging to multi-year highs and attracting robust investor interest. As of November 2025, these traditional safe-haven assets are demonstrating their enduring appeal, buoyed by a complex interplay of
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's stronger-than-expected second-quarter fiscal 2026 earnings report, which showcased robust performance driven by key segments and innovative technology.
November 20, 2025 – The cryptocurrency market is currently navigating a treacherous landscape, with global economic instability acting as a powerful amplifier of its inherent risks. Persistent inflation, aggressive interest rate hikes by central banks, and escalating geopolitical tensions have collectively eroded investor confidence in speculative assets, leading to heightened volatility and significant capital outflows [...]
UBS lifted its upside target to $4,900 from $4,700, saying the factors behind this year’s rally should continue into 2026, according to a report by investing.com.
